Attached files

file filename
EX-32.2 - EX-32.2 - PACIFIC BIOSCIENCES OF CALIFORNIA, INC.pacb-20191231xex32_2.htm
EX-32.1 - EX-32.1 - PACIFIC BIOSCIENCES OF CALIFORNIA, INC.pacb-20191231xex32_1.htm
EX-31.2 - EX-31.2 - PACIFIC BIOSCIENCES OF CALIFORNIA, INC.pacb-20191231xex31_2.htm
EX-31.1 - EX-31.1 - PACIFIC BIOSCIENCES OF CALIFORNIA, INC.pacb-20191231xex31_1.htm
EX-21.1 - EX-21.1 - PACIFIC BIOSCIENCES OF CALIFORNIA, INC.pacb-20191231xex21_1.htm
EX-4.2 - EX-4.2 - PACIFIC BIOSCIENCES OF CALIFORNIA, INC.pacb-20191231xex4_2.htm
10-K - 10-K - PACIFIC BIOSCIENCES OF CALIFORNIA, INC.pacb-20191231x10k.htm

Exhibit 23.1


CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM





We consent to the incorporation by reference in the following Registration Statements:



(1)

 

Registration Statements (Forms S-8, Nos. 333-170211, 333-179810, 333-186065, 333-193437, 333-201678, 333-209157, 333-215746, 333-222696, 333- 229368 and 333-236061) pertaining to the Pacific Biosciences of California, Inc. 2010 Equity Incentive Plan, the Pacific Biosciences of California, Inc. 2010 Employee Stock Purchase Plan, and the Pacific Biosciences of California, Inc. 2010 Outside Director Equity Incentive Plan of Pacific Biosciences of California, Inc.; and



(2)

 

Registration Statements (Forms S-3, Nos. 333-180533, 333-187363, 333-199891, 333-218753, and 333-219642) and related Prospectuses of Pacific Biosciences of California, Inc.;

of our reports dated February 28, 2020, with respect to the consolidated financial statements of Pacific Biosciences of California, Inc. and the effectiveness of internal control over financial reporting of Pacific Biosciences of California, Inc. included in this Annual Report (Form 10-K) of Pacific Biosciences of California, Inc. for the year ended December 31, 2019.

/s/ Ernst & Young LLP 



Redwood City, California

February 28, 2020